Pure Diagnostic Pharmacogenetic Testing provides insight into a patient’s genetic propensity to experience a drug-to-drug interaction or to be non-responsive with certain medication classes
This information is invaluable to clinicians whether they are initiating therapy or evaluating a patient’s progress. We evaluate 49 separate genes and over 120 variants to create an easy to understand report on 15 drug classes and 182 pharmacologic agents. This provides clinicians with one of the most robust reports in the industry and will help guide the clinician’s choices in pharmacotherapy.
Currently, Pure Diagnostic offers Pharmacogenetic Testing Panels for the following medication classes: